NCT04331028

Brief Summary

The extracorporeal shock wave therapy (ESWT) has shown good results in bones and soft tissues of the lower and upper extremities such as: pseudoarthrosis, promoting bone formation of delayed or nonunion fractures, tendinopathies, fascitis and even in vascular pathologies. The investigators main hypothesis is that the application of extracorporeal shock wave therapy (ESWT) in the residual alveolar bone after an extraction of an anterior upper maxillary tooth should prevent further residual alveolar bone resorption and will enhance vital bone formation. The investigators null hypothesis is that applying extracorporeal shock wave therapy (ESWT) in the residual alveolar bone after an extraction of an anterior upper maxillary tooth has no influence in the alveolar bone remodeling process. Therefore, the investigators main objective is to evaluate the efficacy of the ESWT in the prevention of alveolar bone resorption after an extraction with a volumetric exam through computer tomographies (CT) analysis. The investigators secondary objective is to determine the effect of ESWT in the internal bone healing process of these postextraction alveolar sockets, measuring the bone density in the CT (Hounsfield units) and the histomorphometric exam. Methodology: randomized and open clinical trial with 20 patients (10 per group: with or without ESWT treatment) that comply the inclusion and exclusion criteria. In the first appointment the tooth extraction will be performed, while in the second visit (two weeks later), CT scan will be made to all patients and ESWT will be applied in the experimental group. Finally, in the third visit (ten weeks later), a new CT scan will be done and an implant will be placed in the zone taking previously a bone sample with a trephine bur. The expected results are an improvement in the quantity and quality of the alveolar bone before the implant placement.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

December 11, 2014

Completed
5.3 years until next milestone

First Posted

Study publicly available on registry

April 2, 2020

Completed
Last Updated

April 2, 2020

Status Verified

March 1, 2020

Enrollment Period

2 months

First QC Date

December 11, 2014

Last Update Submit

April 1, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Bone volume

    Measured in Cone Beam Computer Tomography

    10 weeks

  • Histomorphometry

    10 weeks

Study Arms (2)

Shockwave therapy

EXPERIMENTAL

After dental extraction, a shockwave therapy will be applied to the area.

Device: Shockwave therapy

Control

NO INTERVENTION

After dental extraction, no treatment will be applied

Interventions

A shockwave therapy device will be applied in the alveolar socket area of a maxillary tooth, 2 weeks after tooth extraction was performed.

Shockwave therapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages between 18 - 65 years old.
  • Non-smoking patients.
  • Patients committed to rehabilitate the extraction socket with an implant.
  • Lack of pathology in the surrounding area.
  • Cooperative patients with serious commitment to follow the investigator's postoperative visits, who must sign the informed consent.
  • Patients that need a conventional anterior maxillary single tooth extraction.

You may not qualify if:

  • Systemic illnesses (ASA III or above) that could contraindicate a surgical intervention or modify the wound healing.
  • Patients with cardiopathies.
  • Patients taking hormones, calcium or oral or endovenous bisphosphonates.
  • Patients with uncontrolled periodontitis / periimplantitis.
  • Smokers.
  • Patients with implant/s in the upper maxilla.
  • Surgical extractions that require rising a flap or ostectomy.
  • Bone defects larger of 2 mms in alveolar sockets due to cortical bone defect or resorption, fenestrations or/and dehiscences.
  • Guided bone regeneration need.
  • Periapical radiolucency larger than 2-3 mms.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Odontologic

L'Hospitalet de Llobregat, Barcelona, 08907, Spain

Location

MeSH Terms

Conditions

Bone Resorption

Interventions

Extracorporeal Shockwave Therapy

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Rui Rui, DDS, MS, PhD

    University of Barcelona

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor; IDIBELL researcher

Study Record Dates

First Submitted

December 11, 2014

First Posted

April 2, 2020

Study Start

October 1, 2014

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

April 2, 2020

Record last verified: 2020-03

Locations